Summary
In rabbits, both the stimulation of α1-adrenoceptors and ischemic preconditioning (PC) reduce infarct size. One candidate for the mechanism of PC is noradrenaline (NA), which stimulates α1-adrenoceptors in the myocardium during PC. Opening of the KATP channel is considered to be another candidate for PC, since a KATP channel blocker, glibenclamide, blocks the infarct size-reducing effect of the PC of 5-min ischemia and 5-min reperfusion in rabbits anesthetized with ketamine + xylazine. However, in rabbits anesthetized with pentobarbital, the infarct size-reducing effect of PC was not blocked by glibenclamide. The effect of glibenclamide on the PC effect thus differs depending on the anesthesia used. Therefore, we speculated that the increase in cardiac interstitial NA levels induced by PC may be modified by the anesthesia used, thus regulating the effect of glibenclamide on the PC effect. In open-chest Japanese white male rabbits anesthetized with pentobarbital or ketamine + xylazine, myocardial interstitial NA levels were measured before and during the PC of 5-min ischemia and 5-min reperfusion in the presence or absence of the KATP channel blocker, glibenclamide (0.3mg/kg, i.v.), using a microdialysis technique. The NA levels were measured using high-performance liquid chromatography coupled with electrochemical detection. The PC of 5-min ischemia and 5-min reperfusion significantly elevated the interstitial NA level. This increase in the NA level was not blocked by glibenclamide under anesthesia with pentobarbital. Under anesthesia with ketamine + xylazine, the PC did not cause an increase in the myocardial interstitial NA level in either the absence or the presence of glibenclamide. In conclusion, PC elevates the myocardial interstitial NA level, and this elevation is not mediated through the opening of the KATP channel under anesthesia with pentobarbital. Under anesthesia with ketamine + xylazine, PC does not cause an increase in the myocardial interstitial NA level. This may explain the discrepancy in the blocking effect of glibenclamide on the infarct size-reducing effect of PC between anesthesia with pentobarbital and ketamine + xylazine.
Similar content being viewed by others
References
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136
Li GC, Vasquez JA, Gallagher KP, Lucchesi BR (1990) Myocardial protection with preconditioning. Circulation 82:609–619
Scott RJ, Rohmann S, Braun ER, Schaper W (1990) Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66:1133–1142
Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM (1991) Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84:350–356
Yellon DM, Alkhulaifi AM, Browne EE, Pugsley WB (1992) Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res 26:983–987
Bankwara Z, Hale SL, Kloner RA (1994) α-Adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. Circulation 90:1023–1028
Tsuchida A, Liu Y, Liu GS, Cohen MV, Downey JM (1994) α1-Adrenergic agonist precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 75:576–585
Thornton JD, Daly JF, Cohen MV, Yang XM, Downey JM (1993) Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ Res 73:649–655
Lock-Winter CR, Winter CB, Nelson DW, Banerjee A (1994) cAMP stimulation facilitates preconditioning against ischemia-reperfusion through norepinephrine and alpha-1 mechanisms (abstract). Circulation 84 (Suppl 2):II-433
Toombs CF, Wiltse AL, Shebuski RJ (1993) Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium: implication of norepinephrine release in the preconditioning effect. Circulation 88 (part 1):2351–2358
Hu K, Nattel S (1995) Mechanisms of ischemic preconditioning in rat hearts — involvement of α1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 92:2259–2265
Kariya T, Minatoguchi S, Ohno T, Yamashita K, Uno Y, Arai M, Koshiji M, Fujiwara T, Fujiwara H (1997) Infarct size-reducing effect of ischemic preconditioning is related to α1b-adrenoceptors but not to α1a-adrenoceptors in rabbits. J Cardiovasc Pharmacol 30:437–445
Gross GJ, Auchampach JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70:223–233
Thornton JD, Thornton CS, Sterling DL, Downey JM (1993) Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res 72:44–49
Toombs CF, Moore TL, Shebuski RJ (1993) Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res 27:617–622
Tanaka M, Fujiwara H, Yamasaki K, Sasayama S (1994) Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res 28:980–986
Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM (1995) Role of bradykinn in protection of ischemic preconditioning in rabbit hearts. Circ Res 77:611–621
Ytreus K, Liu Y, Downey J (1994) Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266:H1145-H1152
Dekker LR, Fiolet JW, VanBavel E, Coronel R, Opthof T, Spaan JA, Janse MJ (1996) Intracellular Ca2+, intercellular electrical coupling, and mechanical activity in ischemic rabbit papillary muscle. Effect of preconditioning and metabolic blockade. Circ Res 79:237–246
Minatoguchi S, Kariya T, Uno Y, Arai M, Ohno M, Hashimoto K, Hujiwara H (1996) Preconditoioning elevates cardiac interstitial noradrenaline and its modulation by adenosine receptor or protein kinase C in rabbits. J Mol Cell Cardiol 28:A314
Kitakaze M, Hori M, Tamai J, Iwakura K, Koretsune Y, Kagiya T, Iwai K, Kitakaze A, Inoue M, Kawada T (1987) α1-adrenoceptor activity regulates release of adrenosine from the ischemic myocardium in dogs. Circ Res 60:631–639
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Minatoguchi, S., Kariya, T., Uno, Y. et al. Modulation of cardiac interstitial noradrenaline levels through KATP channels during ischemic preconditioning in rabbits: comparison of the effect of anesthesia between pentobarbital and ketamine + xylazine. Heart Vessels 12, 294–299 (1997). https://doi.org/10.1007/BF02766806
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02766806